Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,727,543
+$446,272 QoQ
Shares Held
14,813
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#1,500
of 4,153 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 83%
Shared 17%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New Hampshire holds $10,401,676 across 11 Drug Manufacturers - General names. ABBV ranks #2 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,724 | $3,739,454 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
14,813 | $3,727,543 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,478 | $1,089,423 | |
| 4 | LLY |
ELI LILLY & Co
|
605 | $725,655 | |
| 5 | AMGN |
Amgen Inc
|
1,335 | $483,430 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,042 | $405,760 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,400 | $176,876 | |
| 8 | NVS |
Novartis AG
|
255 | $39,963 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,727,543 | 14,813 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,281,271 | 15,087 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $3,367,257 | 14,737 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $3,413,362 | 14,742 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $2,767,037 | 14,907 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,302,663 | 15,763 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,870,210 | 16,152 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $3,319,638 | 16,810 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,935,050 | 17,112 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $3,416,196 | 18,760 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $2,976,508 | 19,207 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,937,867 | 26,418 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,579,776 | 26,570 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $4,224,261 | 26,506 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $4,382,216 | 27,116 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $3,881,084 | 28,918 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $4,462,929 | 29,139 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $4,949,218 | 30,530 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,117,107 | 30,407 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $3,824,422 | 35,454 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $3,993,538 | 35,454 | Shares | Sole | 2021-07-06 | |
| No filing history on record for this holder in this stock. | ||||||